Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD)

Articolo
Data di Pubblicazione:
2021
Citazione:
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) / Falagario, Ugo Giovanni; Jambor, Ivan; Lantz, Anna; Ettala, Otto; Stabile, Armando; Taimen, Pekka; Aronen, Hannu J; Knaapila, Juha; Perez, Ileana Montoya; Gandaglia, Giorgio; Fossati, Nicola; Martini, Alberto; Cucchiara, Vito; Picker, Wolfgang; Haug, Erik; Ratnani, Parita; Haines, Kenneth; Lewis, Sara; Sujit, Nair; Selvaggio, Oscar; Sanguedolce, Francesca; Macarini, Luca; Cormio, Luigi; Nordström, Tobias; Tewari, Ash; Briganti, Alberto; Boström, Peter J; Carrieri, Giuseppe. - In: EUROPEAN UROLOGY ONCOLOGY. - ISSN 2588-9311. - 4:6(2021), pp. 971-979. [Epub ahead of print] [10.1016/j.euo.2020.08.014]
Abstract:
Previous studies suggested that prostate-specific antigen (PSA) density (PSAd) combined with magnetic resonance imaging (MRI) may help avoid unnecessary prostate biopsy (PB) with a limited risk of missing clinically significant prostate cancer (csPCa; Gleason grade group [GGG] >1).
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Biopsy naive; Magnetic resonance imaging; Previous negative biopsy; Prostate cancer; Prostate-specific antigen density
Elenco autori:
Autori di Ateneo:
Link alla scheda completa:
https://iris.unisr.it/handle/20.500.11768/108561
Pubblicato in:
EUROPEAN UROLOGY ONCOLOGY
Journal